ResearcherNanjing University of Chinese MedicineActive in the last 2 years
Wenli Qiu
Matched on ORCID iD 0000-0002-3019-7321; OpenAlex author ID A5075179364. Sources: OpenAlex.
Their work
- Papers
- 9
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 9
- Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography Co-author DOI 10.21203/rs.3.rs-10196272/v1↗
- Tumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment. Co-author DOI 10.2147/ijn.s624679↗
- Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine. Co-author DOI 10.1002/adhm.202302195↗
- Exogenous HMGB1 Promotes the Proliferation and Metastasis of Pancreatic Cancer Cells. Co-author DOI 10.3389/fmed.2021.756988↗
- Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.01618↗
- Pancreatic Ductal Adenocarcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis For Prediction Of Histopathological Grade. Co-author DOI 10.2147/cmar.s218414↗
- A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy. Co-author DOI 10.2217/nnm-2019-0063↗
- Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images. Co-author DOI 10.3389/fonc.2019.01171↗
- Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer. Co-author DOI 10.2147/ijn.s177993↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhongqiu Wang · 8 shared papers, 2018–2026 · strength 1.19
- Paper Tumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment. DOI 10.2147/ijn.s624679↗
- Paper Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine. DOI 10.1002/adhm.202302195↗
- Paper Exogenous HMGB1 Promotes the Proliferation and Metastasis of Pancreatic Cancer Cells. DOI 10.3389/fmed.2021.756988↗
- Shuai Ren · 7 shared papers, 2019–2026 · strength 1.11
- Paper Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using contrast-enhanced co… DOI 10.21203/rs.3.rs-10196272/v1↗
- Paper Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine. DOI 10.1002/adhm.202302195↗
- Paper Exogenous HMGB1 Promotes the Proliferation and Metastasis of Pancreatic Cancer Cells. DOI 10.3389/fmed.2021.756988↗
- Kai Guo · 3 shared papers, 2019–2024 · strength 0.41
- Paper Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine. DOI 10.1002/adhm.202302195↗
- Paper Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinom… DOI 10.3389/fonc.2020.01618↗
- Paper A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy. DOI 10.2217/nnm-2019-0063↗
- Lina Song · 3 shared papers, 2018–2024 · strength 0.38
- Paper Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine. DOI 10.1002/adhm.202302195↗
- Paper A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy. DOI 10.2217/nnm-2019-0063↗
- Paper Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer. DOI 10.2147/ijn.s177993↗
- Zi Wang · 1 shared paper, 2026 · strength 0.36
- Rong Chen · 3 shared papers, 2019–2020 · strength 0.31
- Paper Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinom… DOI 10.3389/fonc.2020.01618↗
- Paper Pancreatic Ductal Adenocarcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis For Predicti… DOI 10.2147/cmar.s218414↗
- Paper Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adeno… DOI 10.3389/fonc.2019.01171↗
- Huifeng Zhang · 2 shared papers, 2019–2024 · strength 0.30
- Xiao Chen · 3 shared papers, 2018–2019 · strength 0.28
- Paper Pancreatic Ductal Adenocarcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis For Predicti… DOI 10.2147/cmar.s218414↗
- Paper Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adeno… DOI 10.3389/fonc.2019.01171↗
- Paper Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer. DOI 10.2147/ijn.s177993↗
- Rui Zhao · 2 shared papers, 2019–2020 · strength 0.21
- Paper Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinom… DOI 10.3389/fonc.2020.01618↗
- Paper Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adeno… DOI 10.3389/fonc.2019.01171↗
- Li Zhu · 1 shared paper, 2021 · strength 0.14
- Yingying Cao · 1 shared paper, 2020 · strength 0.11
- Jingjing Zhang · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.